BioAlliance
18375 Ventura Boulevard
Tarzana
California
91356
United States
Tel: 800-417-1886
Fax: 818-990-3798
Email: allison@bioalliance.com
10 articles about BioAlliance
-
BioAlliance Strengthens the Protection of Livatag(R) (doxorubicin Transdrug(TM) with the Grant of a European Patent
7/12/2011
-
Board Evolution at BioAlliance to Support Its Growth Strategy
5/23/2011
-
Board Evolution at BioAlliance to Support Its Growth Strategy
5/20/2011
-
BioAlliance Expands its Loramyc(R) Franchise in Japan with Sosei Co., Ltd. in a Deal Valued up to $18.5 Million
5/11/2011
-
BioAlliance: Consolidated Accounts for the First Semester of 2010
8/25/2010
-
BioAlliance Receives 6.4 Million Euro in Funding
3/17/2009
-
BioAlliance Announces the Grant of its Main Patent on the Lauriad(R) Technology in Europe
8/22/2008
-
BioAlliance Expands LoramycTM Franchise by Signing a South East Asia Deal Worth up to $12M
3/31/2008
-
BioAlliance Receives Market Approval for Loramyc(R) in Germany, Belgium and Luxemburg
3/26/2008
-
Immtech Pharmaceuticals, Inc. and BioAlliance Sign Licensing Agreement for Pafuramidine
12/5/2007